Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: Implications for autoimmunity and tumor immunity

Microbes and Infection

Volumn 3, Issue 11, 2001, Pages 911-918

  Sakaguchi, Shimon ^a   Takahashi, Takeshi ^a   Yamazaki, Sayuri ^a   Kuniyasu, Yuhshi ^b   Itoh, Misako ^b   Sakaguchi, Noriko ^a   Shimizu, Jun ^b  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Autoimmunity; CD25; Regulatory T cells; Self tolerance, immunologic; Tumor immunity

Indexed keywords

BASILIXIMAB; CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CLONAL ANERGY; DISEASE MODEL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPOIESIS; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; T LYMPHOCYTE; THYMUS; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALIA;

EID: 0034852416     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01452-6     Document Type: Review

References (50)

1. Tumor antigens recognized by T lymphocytes
2. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy
3. Immune response to a differentiation antigen induced by altered antigen: A study of tumor rejection and autoimmunity
4. Homeostasis and self tolerance in the immune system: Turning lymphocytes off
5. Regulatory T cells: Key controllers of immunologic self tolerance
6. A model of developmentally acquired thymus-dependent tolerance to central and peripheral antigens
7. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity
8. Regulatory T cells in autoimmunity
9. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural self tolerance: Deficit of a T-cell subset as a possible cause of autoimmune disease
10. bright normal T cells for the induction of thyroiditis
11. Tolerance mechanism in experimental ovarian and gastric autoimmune disease
12. low subset
13. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats
14. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): Breakdown of a single mechanism of self tolerance causes various autoimmune diseases
15. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
16. + helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rats
17. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
18. Restricted expression of p55 interleukin 2 receptor (CD25) on human T cells
19. The murine IL-2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells
20. + immunoregulatory T cells is antigen nonspecific
21. + T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation
22. + naturally anergic and suppressive T cells; induction of autoimmune disease by breaking their anergic/suppressive state
23. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
24. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self tolerance
25. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalitis
26. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines
27. + T cells
28. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
29. Anergic T cells as suppressor cells in vitro
30. Anergic T cells actively suppress T cell responses via the antigen-presenting cell
31. + immunoregulatory T cells that control autoimmune diabetes
32. + regulatory cells which control intestinal inflammation
33. + regulatory T cells constitutively expressing CTLA-4
34. The emerging role of CTLA-4 as an immune attenuator
35. Is CTLA-4 a master switch for peripheral T cell tolerance?
36. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis
37. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
38. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
39. Induction of anti-self-immunity to cure cancer
40. + T cells: A common basis between tumor immunity and autoimmunity
41. Tumor rejection by in vitro administration of anti-CD25 (Interleukin-2 receptor α) monoclonal antibody
42. - cells
43. Enhancement of antitumor immunity by CTLA-4 blockade
44. Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus/T cells, and not self-antigens
45. Regulation of the immune response to tumor antigen. I. Immunosuppressor cells in tumor-bearing hosts
46. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
47. + T cell mediated immunity
48. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes
49. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
50. Cancer vaccines